Is a complete TPEX/6576 research report available?

No complete published report is available for tpex/6576 (TPEX/6576) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

tpex/6576 stock profile: metrics, valuation and analysis

Market cap	12.7B
Revenue (ttm)	471.1M
Net income (ttm)	22.5M
EPS (ttm)	NT$0.14
Shares out	157.5M
P/E (trailing)	565.8x
Volume	162,352
Beta	0.58

All TPEX/6576 indicators

Market & fundamental data

Available fields

190

Groups with data

Currency

TWD

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 11.8B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	40.55
Isin	TW0006576002
Last refreshed	2026-09-12
Market cap	TWD 12.7B
Price	TWD 80.8
Price currency	TWD
Sector	Healthcare
Sector PE	88.31
Sector PE Fwd	27.72
Sic	2834
Symbol	tpex/6576
Website	https://www.foreseepharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.18%
EV Earnings	526.71x
EV/Sales	25.15x
FCF yield	-4.67%
P/B ratio	10x
P/E ratio	565.85x
P/S ratio	27.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-104.5%
EBITDA Margin	-96.39%
Gross margin	77.7%
Gross Profit	TWD 366.1M
Gross Profit Growth	39.5%
Gross Profit Growth Q	308.14%
Gross Profit Growth3 Y	104.63%
Gross Profit Growth5 Y	1.74%
Net Income	TWD 22.5M
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Pretax Margin	18.94%
Profit Margin	4.77%
ROA	-17.97
Roa5y	-28.47
ROCE	-28.46
ROE	2
Roe5y	-64.12
ROIC	-19.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	0.84%
Cagr1y	-3.93%
Cagr3y	-0.03%
Cagr5y	0.2%
EPS Growth Quarters	4
EPS Growth Years	2
Revenue Growth	6.41x
Revenue Growth Q	62.7x
Revenue Growth Qo Q	126.18x
Revenue Growth Quarters	1x
Revenue Growth Years	2x
Revenue Growth3 Y	71.28x
Revenue Growth5 Y	2.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.28
Assets	TWD 1.9B
Cash	TWD 910.9M
Current Assets	TWD 1.2B
Current Liabilities	TWD 128.8M
Debt	TWD 30.5M
Debt Equity	TWD 0.02
Debt FCF	TWD -0.05
Equity	TWD 1.3B
Interest Coverage	-58.58
Liabilities	TWD 585.6M
Long Term Assets	TWD 701.4M
Long Term Liabilities	TWD 456.8M
Net Cash	TWD 880.4M
Net Cash By Market Cap	TWD 6.92
Net Cash Growth	42.81%
Net Debt Equity	TWD -0.69
Tangible Book Value	TWD 1.2B
Tangible Book Value Per Share	TWD 7.48
WACC	7.42

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.98
Inventory Turnover	0.69
Net Working Capital	TWD 134.6M
Quick ratio	7.57
Working Capital	TWD 1B
Working Capital Turnover	TWD 0.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.89%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	8.76%
1Y total return	-3.92%
200-day SMA	79.92
3Y total return	-0.1%
50-day SMA	80.77
50-day SMA vs 200-day SMA	50over200
5Y total return	1.01%
All Time High	141
All Time High Change	-42.7%
All Time High Date	2022-03-25
All Time Low	35.1
All Time Low Change	130.2%
All Time Low Date	2020-03-23
ATR	1.58
Beta	0.58
Beta1y	0.2
Beta2y	0.45
Ch YTD	0.25
High	80.8
High52	93.7
High52 Date	2025-11-17
High52ch	-13.77%
Low	78.9
Low52	71.9
Low52 Date	2025-11-25
Low52ch	12.38%
Ma50ch	0.04%
Price vs 200-day SMA	1.1%
RSI	51.3
RSI Monthly	50.18
RSI Weekly	52.81
Sharpe ratio	-0.02x
Sharpe Ratio3y	-0.03x
Sharpe Ratio5y	-0.06x
Sortino ratio	0.27
Sortino Ratio3y	0.19
Sortino Ratio5y	0.1
Total Return	-6.89%
Tr YTD	0.25
Tr1m	1.51%
Tr1w	1%
Tr3m	1%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	100,301,164%
Net Borrowing	154,046,000
Shares Insiders	12.67%
Shares Institutions	1.09%
Shares Out	157,540,541
Shares Qo Q	-0.6%
Shares Yo Y	6.89%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -610.7M
Adjusted OCF	-561,423,000
Average Volume	111,260.65x
Bv Per Share	8.12
CAPEX	TWD -49.3M
Ch10y	4.95
Ch1m	1.51
Ch1w	1
Ch1y	-3.92
Ch3m	1
Ch3y	-0.12
Ch5y	-0.12
Ch6m	0.12
Change	-0.37%
Change From Open	0.75
Close	81.1
Days Gap	-1.11
Depreciation Amortization	38,171,000
Dollar Volume	13,118,041.6
Earnings Date	2026-11-12
EBIT	TWD -492.3M
EBITDA	TWD -454.1M
EPS	TWD 0.14
F Score	3
FCF	TWD -594.5M
FCF EV Yield	-5.02x
FCF Per Share	TWD -3.77
Financing CF	348,226,000
Fiscal Year End	December
Founded	2,013
Graham Number	5.12576
Graham Upside	-93.66
Income Tax	TWD 66.8M
Investing CF	183,010,000
Is Primary Listing	1
Last Earnings Date	2026-02-24
Last Report Date	2026-06-30
Ma150	80.14
Ma150ch	0.82%
Ma20	80.41
Ma20ch	0.49%
Net CF	10,571,000
Next Earnings Date	2026-11-12
Open	80.2
Position In Range	100
Ppne	190,251,000
Price Date	2026-09-11
Ptbv Ratio	10.87
Relative Volume	1.41x
Revenue	471,126,000x
SBC By Revenue	3.45x
Share Based Comp	16,270,000
Tax By Revenue	14.17x
Tax Rate	74.79%
Tr6m	0.12%
Volume	162,352

TPEX/6576 (TPEX/6576)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/6576

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/6576 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TPEX/6576

Frequently asked questions